Novo Nordisk’s Once-Weekly Insulin Gains Superiority Finding As Lilly Advances

Novo Nordisk announced data from the ONWARDS 1 and 6 trials of insulin icodec • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapy Areas